Dr. Leimbach is a specialist in interventional cardiology with expertise in cardiac catheterization, coronary intervention (including angioplasty, stent placement, atherectomy, intravascular ultrasound), peripheral vascular interventions, such as carotid stenting, as well as interventional therapies for structural heart disease, such as percutaneous closure of PFOs, ASDs and PDAs, and percutaneous placement of stent valves (TAVR).
Dr. Leimbach is director of the Cardiac and Interventional Laboratories and medical director at Oklahoma Heart Institute Hospital at Hillcrest Medical Center. He is Co-Founder of the Lipid and Wellness Clinic at Oklahoma Heart Institute. He is director of the James D. Harvey Center for Cardiovascular Research at Hillcrest Medical Center, as well as director of the Oklahoma Heart Research and Education Foundation. Dr. Leimbach also serves as clinical associate professor of medicine at the University of Oklahoma College of Medicine – Tulsa.
Clinical Cardiology - University of Iowa Hospitals and Clinics in Iowa City, Iowa
Research - University of Iowa Hospitals and Clinics in Iowa City, Iowa
INTERNSHIP & RESIDENCY
Internal Medicine - University of Iowa Hospitals and Clinics in Iowa City, Iowa, where he was selected chief resident in medicine
Medical degree - Northwestern University in Chicago, Illinois
Bachelor of Science degree - University of Michigan in Ann Arbor, Michigan
Board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology
Dr. Leimbach also practices at the Oklahoma Heart Institute Clinic in Claremore.
For clinic location and directions, click here.